ID: ALA5287439

Max Phase: Preclinical

Molecular Formula: C17H14ClNO2

Molecular Weight: 299.76

Associated Items:

Representations

Canonical SMILES:  COc1ccc(C(=O)n2c(C)cc3cc(Cl)ccc32)cc1

Standard InChI:  InChI=1S/C17H14ClNO2/c1-11-9-13-10-14(18)5-8-16(13)19(11)17(20)12-3-6-15(21-2)7-4-12/h3-10H,1-2H3

Standard InChI Key:  QRNXCXNJRQTIAH-UHFFFAOYSA-N

Associated Targets(Human)

LNCaP C4-2B 271 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 299.76Molecular Weight (Monoisotopic): 299.0713AlogP: 4.30#Rotatable Bonds: 2
Polar Surface Area: 31.23Molecular Species: NEUTRALHBA: 3HBD: 0
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: CX LogP: 3.89CX LogD: 3.89
Aromatic Rings: 3Heavy Atoms: 21QED Weighted: 0.71Np Likeness Score: -1.21

References

1. Ha S, Luo G, Xiang H..  (2022)  A Comprehensive Overview of Small-Molecule Androgen Receptor Degraders: Recent Progress and Future Perspectives.,  65  (24.0): [PMID:36459083] [10.1021/acs.jmedchem.2c01487]

Source